Synthetic-biological hybrid nanocapsule combats diseased cells
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases...
List view / Grid view
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases...
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
In vitro study verifies method for remotely triggering release of cancer drugs...
Company establishes its presence in South Korea...
A topical gel made from a class of common blood pressure medications has been found to accelerate the healing process of chronic skin wounds...
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
FDA collaboration will characterise the performance of Organs-on-Chips as a platform for potential use in drug development and regulatory evaluation...
In this issue Dave Elder discusses issues around the manufacture of film coatings and Adeyinka Aina and colleagues consider the potential medicinal uses and efficacy of the flavonoids epigallocatechin and epicatechin, which can be extracted from the Spondias mombin plant.
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
Inflammatory cells retain drug after it disappears from circulation, improving delivery to regenerating muscle cells...
Researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer...
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
Researchers have identified that stroke patients with dementia treated with IVT, using clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients...
Researchers have collaborated to design a smart bandage that could eventually heal chronic wounds...
Dante J Marciani, President and CSO of Qantu Therapeutics, reviews the current evidence and controversy in the hunt for a vaccine against Alzheimer's disease and considers the future.